4.6 Article

Genetic Variations in GRIA1 on Chromosome 5q33 Related to Asparaginase Hypersensitivity

Journal

CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 88, Issue 2, Pages 191-196

Publisher

WILEY
DOI: 10.1038/clpt.2010.94

Keywords

-

Funding

  1. National Cancer Institute [CA 21765]
  2. NIH/NIGMS Pharmacogenetics Research Network and Database [U01 GM61393, U01GM61374]
  3. American Lebanese Syrian Associated Charities

Ask authors/readers for more resources

The genetic variations that result in allergy to asparaginase are as yet undetermined. We interrogated more than 500,000 single-nucleotide polymorphisms (SNPs) in 485 children with acute lymphoblastic leukemia (ALL), 322 in a discovery cohort, and 163 in a validation cohort. In the top 100 SNPs associated with allergy in the discovery cohort, chromosome 5 was overrepresented as compared with other chromosomes (P = 0.00032), hosting 10 SNPs annotated to genes. Among these 10 SNPs, one SNP (rs4958381), in GRIA1 on chromosome 5q33, was replicated in the validation cohort (P = 1.8 x 10(-5), 2.9 x 10(-3), and 3.5 x 10(-7) in the discovery, validation, and combined cohorts, respectively). Four additional SNPs annotated to GRIA1 were also significantly associated with allergy (P < 0.05) in both cohorts. Chromosome 5q33 has previously been associated with asthma and atopy. These data contribute to the growing body of evidence that there is an inherited component to predisposition to drug allergy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available